Literature DB >> 22248366

Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark.

H H Nielsen1, J Qiu, S Friis, L Wermuth, B Ritz.   

Abstract

BACKGROUND AND
PURPOSE: It has been speculated that gastrointestinal infection with Helicobacter pylori (HP) contributes to the development of Parkinson's disease (PD). We used nationwide Danish registers to investigate this hypothesis.
METHODS: We identified 4484 patients with a first time PD diagnosis between 2001 and 2008 from the Danish National Patient Register (DNPR) and 22, 416 population controls from the Danish Civil Registration System (CRS). Information on drug use was obtained from the National Prescription Registry (NPR). We used logistic regression to compute odds ratios (OR) for the association between treatment for HP and risk of PD.
RESULTS: Prescriptions for HP-eradication drugs and proton pump inhibitors (PPI) 5 or more years prior to the diagnosis of PD were associated with a 45% and 23% increase in PD risk, respectively. Hospitalizations and outpatient visits for gastritis and peptic/duodenal ulcers, however, were not associated with PD.
CONCLUSIONS: Our population-based study suggests that chronic HP infections and/or gastritis contribute to PD or that these are PD-related pathologies that precede motor symptoms.
© 2012 The Author(s). European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248366      PMCID: PMC3330170          DOI: 10.1111/j.1468-1331.2011.03643.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  36 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 2.  Non-motor parkinsonism.

Authors:  Ronald F Pfeiffer
Journal:  Parkinsonism Relat Disord       Date:  2007       Impact factor: 4.891

3.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

4.  Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures.

Authors:  A Dahlström; A Wigander; K Lundmark; C G Gottfries; P M Carvey; A McRae
Journal:  J Neural Transm Suppl       Date:  1990

Review 5.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

6.  Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population.

Authors:  Mette Wildner-Christensen; Jane Møller Hansen; Ove B Schaffalitzky De Muckadell
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

Review 7.  Diagnosis and the premotor phase of Parkinson disease.

Authors:  Eduardo Tolosa; Carles Gaig; Joan Santamaría; Yaroslau Compta
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

8.  Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia.

Authors:  Marion Danzer; Claudia Samberger; Rudolf Schicho; Irmgard Th Lippe; Peter Holzer
Journal:  Eur J Neurosci       Date:  2004-01       Impact factor: 3.386

Review 9.  Multiple roles for nicotine in Parkinson's disease.

Authors:  Maryka Quik; Luping Z Huang; Neeraja Parameswaran; Tanuja Bordia; Carla Campos; Xiomara A Perez
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

10.  Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates.

Authors:  J Hallas; J Lauritsen; H D Villadsen; L F Gram
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

View more
  50 in total

1.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

Review 2.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

3.  Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies.

Authors:  Lei Meng; Liang Shen; Hong-Fang Ji
Journal:  J Neurovirol       Date:  2019-01-10       Impact factor: 2.643

4.  Gut feelings about smoking and coffee in Parkinson's disease.

Authors:  Pascal Derkinderen; Kathleen M Shannon; Patrik Brundin
Journal:  Mov Disord       Date:  2014-04-21       Impact factor: 10.338

Review 5.  Helicobacter pylori and neurological diseases: Married by the laws of inflammation.

Authors:  Lourdes Alvarez-Arellano; Carmen Maldonado-Bernal
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 6.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 7.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

8.  A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity.

Authors:  Ethan Stolzenberg; Deborah Berry; Ernest Y Lee; Alexander Kroemer; Stuart Kaufman; Gerard C L Wong; Joost J Oppenheim; Supti Sen; Thomas Fishbein; Ad Bax; Brent Harris; Denise Barbut; Michael A Zasloff
Journal:  J Innate Immun       Date:  2017-06-27       Impact factor: 7.349

Review 9.  Brain-gut-microbiota axis in Parkinson's disease.

Authors:  Agata Mulak; Bruno Bonaz
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 10.  Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?

Authors:  Christopher J Barnum; Malú G Tansey
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.